Amendment to Commission Agreement between UTEK Corporation and Dr. Wolfram Weinsheimer dated March 28, 2000

Summary

This amendment is between UTEK Corporation and Dr. Wolfram Weinsheimer. It changes Dr. Weinsheimer’s compensation for successful technology transfers from a 10% equity commission to a $20,000 cash commission per sale of a UTEK licensed technology. The change is due to UTEK’s new status as a business development corporation and its legal requirements. Dr. Weinsheimer must agree to the new terms by signing and returning the amendment by April 12, 2000.

EX-10.36 9 g67691ex10-36.txt AMENDMENT DATED 3/28/00 WITH WOLFRAM WEINSHEIMER 1 Exhibit 10.36 March 28, 2000 Dr. Wolfram Weinsheimer Kuerzlengraben 15A D-89275 Elchingen, Germany Dear Wolfram: I hope all is well. In preparation for our public offering, we will be operating as a business development corporation, which has its own legal requirements. Accordingly, we will no longer be able to compensate regional representatives with shares of stock in companies who acquire technologies from us. Instead of the current 10% equity commission upon the consummation of any successful technology transfer (which results from your efforts), we will now provide you with a $20,000 cash commission upon the successful sale of a UTEK licensed technology. If you agree to this new commission program, please sign below and fax back to Carole Mason, CFO, by April 12th, 2000. I appreciate all of your efforts to-date and look forward to our continued mutually beneficial relationship. Very best regards, /s/ Uwe Reischl Uwe Reischl, Ph.D., M.D. President Cc: Sam Reiber Agreed to: /s/ Dr. Wolfram Weinsheimer Date 00-04-06 -------------------------------------- -------------